-
-
The Food and Drug Administration has given approval to Skyla, a new intrauterine system (IUS) from Bayer HealthCare Pharmaceuticals of Wayne, NJ. Available by prescription in February 2013, Skyla is the first new intrauterine contraceptive to receive U.S. approval in more than a decade.
-
Sterilization continues to be a leading contraceptive choice for women in the United States; between 2006 and 2008, 10.3 million women looked to the method for birth control.
-
-
The Food and Drug Administration (FDA) has given clearance to Cepheid of Sunnyvale, CA, to market its Xpert CT/NG test.
-
According to a just-released analysis of the latest national sexually transmitted infection (STI) surveillance data, 1.4 million new cases of chlamydia were reported in the United States in 2011.
-
In one of its final acts, the lame-duck 112th Congress did something unprecedented over its two-year term: It expanded access to publicly financed abortion, ever so slightly.
-
-
Results of a new national survey of obstetricians and gynecologists (OB/GYNs) show that many physicians mistakenly believe a routine annual bimanual pelvic examination is important in screening for ovarian cancer.
-
Since the July 2002 publication of the first Women's Health Initiative (WHI) report, many changes have been made in the approach to hormone therapy (HT).